Age at Breast Cancer Diagnosis and Short-Term Postoperative Outcomes for Women Treated in a Universal Health System
Open Access
- 6 February 2026
- journal article
- Published by SAGE Publications in Cancer Control
- Vol. 33
Abstract
Introduction: Surgery is an essential component of breast cancer treatment. Surgical complications may impact receipt of adjuvant therapy and long-term outcomes. Differences in insurance coverage and access to care by patient age in the general U.S. population may affect breast cancer diagnosis and surgery and thus age comparisons in research. We compared postoperative outcomes following breast cancer surgery between age groups in the U.S. Military Health System, which provides beneficiaries access to comprehensive care across the lifespan. Methods: We identified women aged ≥18 years with stage I–III breast cancer diagnosed from 2001 to 2014 undergoing surgery without reconstruction in the MilCanEpi database. Multivariable Poisson regression estimated the adjusted risk ratios (ARRs) with 95% confidence intervals (CIs) in association with age at diagnosis (18-39, 40-49, 50-64, and ≥65) for 30-day general and breast complications (surgical site infection, seroma, hematoma, or lymphedema), reoperation, and hospital readmission while controlling for potential confounders. Results: The study included 7835 women who were 18-39 (9.2%), 40-49 (23.6%), 50-64 (42.7%), and ≥65 (24.5%). The overall risk of general or breast complications did not differ significantly by age when controlled for demographic, tumor, and treatment variables. However, women aged 40-49 had a statistically increased adjusted risk of seroma (ARR = 1.50; 95% CI = 1.03-2.18) compared to women aged 50-64. No significant age-related differences were observed for reoperation or hospital readmission after adjustment. Conclusion: In the Military Health System, the overall risk of 30-day postoperative complications and hospital readmissions were not statistically different by age after adjustment for clinical and demographic factors. The findings support that surgical decision-making continue to prioritize tumor characteristics, comorbidity burden, and other clinical factors rather than age alone when assessing perioperative risk.Keywords
Funding Information
- U.S. Department of War (HHU0001-16-2-0014)
- U.S. Department of War (HU0001-18-2-0032)
This publication has 61 references indexed in Scilit:
- Effect of age at diagnosis of breast cancer on the patterns and risk of mortality from all causes: A population‐based study in AustraliaAsia-Pacific Journal of Clinical Oncology, 2012
- Cardiopulmonary Function and Age-Related Decline Across the Breast Cancer Survivorship ContinuumJournal of Clinical Oncology, 2012
- Case Definitions for Acute Myocardial Infarction in Administrative Databases and Their Impact on In‐Hospital Mortality RatesHealth Services Research, 2012
- Age, Comorbidity, and Breast Cancer Severity: Impact on Receipt of Definitive Local Therapy and Rate of Recurrence among Older Women with Early-Stage Breast CancerJournal of the American College of Surgeons, 2011
- National Quality Measures for Breast Centers (NQMBC): A Robust Quality ToolAnnals of Surgical Oncology, 2009
- Elevated Breast Cancer Mortality in Women Younger than Age 40 Years Compared with Older Women Is Attributed to Poorer Survival in Early-Stage DiseaseJournal of the American College of Surgeons, 2009
- Tumor Biology of Breast Cancer in Young WomenBreast Disease, 2006
- Estimating the Relative Risk in Cohort Studies and Clinical Trials of Common OutcomesAmerican Journal of Epidemiology, 2003
- Accuracy of ICD-9-CM Coding for the Identification of Patients With Acute Ischemic StrokeStroke, 1998
- Comorbidity Measures for Use with Administrative DataMedical Care, 1998